Home > Boards > US Listed > Medical - Drugs >

Creative Medical Technology Holdings Inc. (CELZ)

Add CELZ Price Alert      Hide Sticky   Hide Intro
Moderator: Dragon Lady, escalate, SmellMyFinger
Search This Board: 
Last Post: 5/20/2022 4:11:33 PM - Followers: 513 - Board type: Free - Posts Today: 0

3008 W Lupine Ave
Phoenix AZ 85029



$CELZ: Massive 1 for 150 Reverse Stock Split of their common shares was implemented on.... Jan 28th, 2020:
(pre reverse split share price was approx .0002 to .0003 per share in early to mid Jan 2020)

Split correct share price as of May 2020 = approx 0.00002 per share (99.9% losses to common shares under current CELZ mgt team)

Quote of SEC 8-K filing:
"Item 3.03   Material Modification to Rights of Security Holders.

Item 5.03.  Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

As previously reported, the Board of Directors and stockholders of Creative Medical Technology Holdings, Inc., a Nevada corporation (the “Company”), have approved a reverse stock split of the Company’s common stock, par value $0.001 per share (the “Common Stock”),at a ratio of 1-for-150 (the “Reverse Stock Split”).

The Reverse Stock Split will become effective pursuant a Certificate of Amendment (the “Certificate”) filed by the Company with the Secretary of State of the State of Nevada on January 28, 2020 pursuant to Nevada Revised Statutes (“NRS”) Sections 78.385 and 78.390. A copy of the Certificate has been filed as Exhibit 3.1 hereto and is incorporated herein by reference."


$CELZ: Massive 1 for 500 Reverse Stock Split of their common shares was implemented on.... Nov 10th, 2021:
(pre reverse split share price was approx 2 cents per share in early Nov 2021 - this is the 2nd massive reverse split in under 2 years that CELZ. common sharholders have experienced causing them to experience literal 99.9% losses to their holdings. Two trading days after the 1-for-500 reverse split of Nov 2021 the split-corrected price had already collapsed to the equivalent of SUB ONE CENT again at approx .0092 per share)


About Us
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. is a commercial-stage biotechnology company focused on Urology and Neurology using stem cell treatments.  Through our own research and collaborations with leading academic institutions, CMTH has acquired a groundbreaking stem cell (Amniostem), developed proprietary protocols, built an extensive intellectual property portfolio, developed complete treatment offerings for erectile dysfunction, launched a 40-patient trial for ED at UCLA and are breaking new ground for treating stroke using our newly acquired amniotic fluid-based stem cell.  Our team consists of leading international researchers in regenerative medicine.  Our “science-first” approach to treatments ensures that all of our treatments are proven to be both safe and effective.  We are currently in the commercial stage of our bone marrow based stem cell treatment for Erectile Dysfunction known as CAVERSTEM, which is being marketed both nationally, and internationally.  

Contact Info

2017 W Peoria Avenue
Phoenix, AZ 85029
Phone: (833) 336-7636






100 Patients Treated For Erectile Dysfunction Utilizing Company's Patented CaverStem® Stem Cell Procedure With Significant Success Rate And No Adverse Effects Reported

General corporate updates and plans for second half of 2019
Jun 20, 2019 7:50 AM EDT
PHOENIX, June 20, 2019 /PRNewswire/ --  Creative Medical Technology Holdings, Inc. (OTCQB: CELZ), a leading commercial stage biotechnology company focused on Urology, Orthopedics and Neurology using stem cell treatments, today announced business updates and plans for remainder of 2019.
Physicians at Tarzana, CA location
Recent Business Highlights
  • CaverStem® Regenerative Stem Cell Procedure for Treatment of Erectile Dysfunction in Men
    • Healthcare Professional (HCP) Recruitment/Training ongoing with 5 new facilities coming onboard in the last 60 days and multiple other locations presently being vetted and scheduled for training.
      Increasing consumer awareness campaigns utilizing print/digital/radio in local regions where CaverStem® is offered successfully driving patients into clinic
      Featured on ABC News as breakthrough technology with potential to help millions of men - many additional requests for media currently being vetted

    FemCelz™ Regenerative Stem Cell Procedure for Treatment of Female Sexual Dysfunction
    • Soft launch utilizing established CaverStem® clinics proving to be effective commercial strategy
      5 additional patients successfully treated in New Mexico within the past 30 days.

    StemSpine™ Regenerative Stem Cell Procedure for Treatment of Degenerative Disc Disease using the patients own bone marrow derived stem cells.
    • As previously announced, the StemSpine program is scheduled for a soft launch in the latter part of 2019. Currently the company continues to focus its efforts on commercialization of its lead out technologies CaverStem® and FemCelz™

    • The AmnioStem technology is the use of stem cells from amniotic fluid which is considered a drug. This process differs significantly from our other technologies whereupon we use the patients own bone marrow derived stem cells. This requires a an investigational new drug application process through the FDA, of which we are highly familiar. We are moving forward with this program and are pleased with the progress.




Creative Medical Technology Holdings Forms CaverStem International LLC

Subsidiary to concentrate on International Erectile Dysfunction Market


PHOENIX and LOS ANGELES, June 19, 2018

PHOENIX and LOS ANGELES, June 19, 2018 /PRNewswire/ -- Creative Medical Technology Holdings (OTCQB:CELZ) announced today the formation of CaverStem International LLC, a majority owned subsidiary focused on commercializing stem cell therapy for erectile dysfunction to international physicians and their patients.

"Due to the enthusiastic response from international attendees at the American Urological Association conference held in May 2018, we've determined it is in the best interest of the company to form a subsidiary to pursue commercialization with physicians from around the world," said Timothy Warbington President and CEO of Creative Medical Technologies, Inc. and Managing Member of CaverStem International LLC.

Dr. Alexander Gershman, an internationally renowned urologist, lecturer, inventor and Scientific Advisory Board Member at Creative Medical Technology Holdings, Inc., will take on an expanded role with CaverStem International, utilizing not only his vast expertise but also his international relationships in the urology community to expand our physician base.  Dr. Gershman is one of the Managers and Members of this subsidiary. "We're excited that Dr. Gershman who was the first physician to treat patients commercially with the CaverStemTM procedure, is taking on this role with the company," Timothy Warbington said further.



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CELZ News: Statement of Changes in Beneficial Ownership (4) 05/20/2022 07:09:46 AM
CELZ News: Notice of Effectiveness (effect) 05/20/2022 02:56:20 AM
CELZ News: Quarterly Report (10-q) 05/13/2022 12:21:32 PM
CELZ News: Securities Registration Statement (simplified Form) (s-3) 05/10/2022 12:16:43 PM
CELZ News: Small Company Offering and Sale of Securities Without Registration (d) 05/05/2022 08:58:58 AM
News News Alert: Statement of Changes in Beneficial Ownership (4) 05/20/2022 07:09:46 AM
#110899  Sticky Note CELZ_a_CON: UNPUBLISHED_BULLSHIT_WORTHLESS_"STUDY"_FROM_BROKE_OTC_SCAM ! Dragon Lady 05/08/22 09:57:58 AM
#110860  Sticky Note Creative Medical Technology Signs Master Collaboration Agreement with Chartmaster 03/31/22 08:33:44 AM
#110904   Lizzo: Truth hurts. That was some haircut today! Lmao uvaphd 05/20/22 04:11:33 PM
#110903   CELZ_a_CON: HEADING_SUB_$1_BUCK_AND_NASDAQ DE-LISTING_LMAO ! Dragon Lady 05/20/22 03:14:33 PM
#110900   Go Celz. NASDAQ. Listing. !!! TOM611 05/09/22 02:51:11 PM
#110898   hahaha it's to laugh you to death, they Tonneke 05/06/22 09:41:23 AM
#110897   So the upshot is that they erroneously and uvaphd 05/05/22 09:19:16 PM
#110896   NEWS .... Notice of Exempt Offering of Securities escalate 05/05/22 05:55:57 PM
#110895   Hoppaaaaaaa Tonneke 05/05/22 05:46:06 PM
#110894   News FORM 8-K escalate 05/04/22 06:00:21 PM
#110893   News https://www.sec.gov/Archives/edgar/data/0001187953/0001477932220029 escalate 05/04/22 05:56:15 PM
#110892   This will see 5plus very soon… I am europtiger 05/04/22 09:06:02 AM
#110891   Institutional investors about to load up. Potentially bullish. SmellMyFinger 05/02/22 10:53:10 AM
#110890   thanks for sharing Tonneke 04/29/22 09:59:03 AM
#110889   $CELZ. News! Creative Medical Technology Announces $17 gint1 04/29/22 08:54:05 AM
#110888   Q1: Based on the information at the following uvaphd 04/27/22 05:13:42 AM
#110887   Form S-1 Filed on April 22, 2022 escalate 04/26/22 03:26:29 PM
#110886   Creative Medical Technology Announces Progress in Developing a escalate 04/24/22 08:59:05 PM
#110885   More dilution from these conmen? No way! uvaphd 04/22/22 10:04:51 PM
#110884   CELZ news alert Dow Jones and Company, Inc.: *Creative gint1 04/22/22 05:53:09 PM
#110883   $CELZ CELZ news alert Benzinga: Creative Medical Technology Announces gint1 04/20/22 08:39:30 AM
#110882   News Awl416 04/20/22 08:38:34 AM
#110881   Go. Oversold. Grab. Cheapies TOM611 04/19/22 08:46:14 AM
#110880   Yep. Basic fundamentals. Gaps get filled (usually). $CELZ SmellMyFinger 04/18/22 09:57:30 AM
#110879   Ok… maybe gapfill is coming LOL Little Strange europtiger 04/18/22 09:50:27 AM
#110878   Yeah never know… I really don’t like gaps, europtiger 04/18/22 09:30:55 AM
#110877   Perhaps, although a gap might be filled first. SmellMyFinger 04/18/22 09:29:01 AM
#110876   $CELZ….. News! https://finance.yahoo.com/news/creative-medical-technology-showca gint1 04/12/22 08:48:27 AM
#110875   Let’s test that four dollaholla today europtiger 04/08/22 11:35:51 AM
#110872   New high incoming! Lock and load! HeilHiden 03/31/22 03:05:00 PM
#110870   Current price isway below sma momentum very HeilHiden 03/31/22 12:17:58 PM
#110869   Only person selling is the MM breakout alertt HeilHiden 03/31/22 12:06:45 PM
#110868   $10.00 price target! Lock and load! HeilHiden 03/31/22 11:39:39 AM
#110867   Selling pressure is fading away HeilHiden 03/31/22 11:33:49 AM
#110866   Classic MM gun stop maneuver HeilHiden 03/31/22 11:25:39 AM
#110865   Way oversold again HeilHiden 03/31/22 11:22:39 AM
#110864   Shares are thin we’re going up! HeilHiden 03/31/22 11:03:11 AM
#110863   Shares ar within $5.00++ HeilHiden 03/31/22 10:54:50 AM
#110862   Where was this kind of activity 4 years uvaphd 03/31/22 10:17:19 AM
#110861   $CELZ…, The Company plans to advance multiple indications gint1 03/31/22 08:41:40 AM
#110860   Creative Medical Technology Signs Master Collaboration Agreement with Chartmaster 03/31/22 08:33:44 AM
#110859   Company 10K: https://www.sec.gov/ix?doc=/Archives/edgar/data/1187953/000147793 lockstock31 03/31/22 01:48:20 AM
#110858   News On The Way!!! dennisv 03/30/22 03:47:20 PM
#110857   Higher Prices Are Coming! Pure Manipulation! dennisv 03/30/22 03:35:58 PM
#110856   We’re skipping penny’s on the way up. Lock HeilHiden 03/30/22 11:02:08 AM
#110855   Way oversold here shares are thin and MM HeilHiden 03/30/22 10:55:05 AM
#110854   Sma momentum is way above current price! Bullish signs! HeilHiden 03/30/22 10:43:22 AM
#110853   Go Celz Many Catalysts.!!!!! TOM611 03/29/22 06:41:36 AM
#110852   10X avg volume today. Televet 03/28/22 08:08:05 PM
#110851   That big drop sell killed the run?? Imo Roadtojourney 03/28/22 03:38:17 PM
#110850   + 700 %, history repeat itself tortiello 03/28/22 03:16:56 PM
Consent Preferences